Eli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically target a protein that plays a role in triggering and maintaining inflammation in psoriasis. Copellor is a prescription medicine that is only to be used on the advice of a dermatologist or rheumatologist and under medical supervision.
